文献速递运动医学关节外科

肱二头肌长头腱切断术与固定术治疗肩关节镜手术患者肱二头肌长头腱病变的前瞻性双盲随机对照试验

Biceps Tenodesis Versus Tenotomy in the Treatment of Lesions of the Long Head of the Biceps Tendon in Patients Undergoing Arthroscopic Shoulder Surgery: A Prospective Double-Blinded Randomized Controlled Trial.
PubMed 文献 · Am J Sports Med · 2020-03-30

该前瞻性双盲随机对照试验纳入114例接受肩关节镜手术且术中确认肱二头肌长头腱病变的患者,随机分为切断术组与固定术组。主要结局ASES评分和WORC评分在两组术后24个月内均显著改善且组间无差异,但切断术组美容畸形(Popeye畸形)发生率显著高于固定术组。

要点

  • 切断术与固定术均能显著改善患者报告的肩关节功能评分,组间无差异。
  • 切断术组术后24个月美容畸形相对风险为固定术组的3.5倍(95%CI 1.26-9.70)。
  • 固定术组术后12个月MRI显示所有患者固定完整,肘屈曲和旋后力量组间无差异。

核心结论

  • 肱二头肌长头腱切断术和固定术治疗肱二头肌长头腱病变均能获得良好的主观功能结果,但切断术组Popeye畸形发生率更高。

研究设计与样本

  • 前瞻性双盲随机对照试验,证据等级1级,纳入114例年龄≥18岁且术中确认肱二头肌长头腱病变并接受肩关节镜手术的患者。

主要发现

  • ASES评分和WORC评分从术前到术后各时间点均显著改善,平均差异分别为32.3%(P < .001)和37.3%(P < .001),两组间从术前到术后24个月无差异。
  • 术后24个月,切断术组相对于固定术组发生美容畸形的相对风险为3.5(95% CI,1.26-9.70;P = .016),固定术组发生4例(10%),切断术组发生15例(33%)。
  • 疼痛从术后3个月到24个月改善(P < .001),组间无差异;抽筋组间无差异,且随时间无改善。
  • 肘屈曲力量和旋后力量组间无差异;术后12个月随访MRI显示固定术组所有患者固定完整。

关键数值与推荐

  • 主要结局为美国肩肘外科医师(ASES)评分,次要结局包括西安大略肩袖指数(WORC)评分、肘和肩力量、手术时间、并发症及翻修手术发生率。
  • 术后24个月美容畸形相对风险为3.5(95% CI,1.26-9.70;P = .016),固定术组4例(10%),切断术组15例(33%)。

临床怎么用

  • 对于接受肩关节镜手术的肱二头肌长头腱病变患者,切断术和固定术均可作为治疗选择,但需告知切断术有更高的Popeye畸形风险。
  • 固定术可维持肌腱完整性,术后12个月MRI显示所有固定术患者固定完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The biceps tendon is a known source of shoulder pain. Few high-level studies have attempted to determine whether biceps tenotomy or tenodesis is the optimal approach in the treatment of biceps pathology. Most available literature is of lesser scientific quality and shows varying results in the comparison of tenotomy and tenodesis. PURPOSE: To compare patient-reported and objective clinical results between tenotomy and tenodesis for the treatment of lesions of the long head of the biceps brachii. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: Patients aged ≥18 years undergoing arthroscopic surgery with intraoperative confirmation of a lesion of the long head of the biceps tendon were randomized. The primary outcome measure was the American Shoulder and Elbow Surgeons (ASES) score, while secondary outcomes included the Western Ontario Rotator Cuff Index (WORC) score, elbow and shoulder strength, operative time, complications, and the incidence of revision surgery with each procedure. Magnetic resonance imaging was performed at postoperative 1 year to evaluate the integrity of the procedure in the tenodesis group. RESULTS: A total of 114 participants with a mean age of 57.7 years (range, 34 years to 86 years) were randomized to undergo either biceps tenodesis or tenotomy. ASES and WORC scores improved significantly from pre- to postoperative time points, with a mean difference of 32.3% (P < .001) and 37.3% (P < .001), respectively, with no difference between groups in either outcome from presurgery to postoperative 24 months. The relative risk of cosmetic deformity in the tenotomy group relative to the tenodesis group at 24 months was 3.5 (95% CI, 1.26-9.70; P = .016), with 4 (10%) occurrences in the tenodesis group and 15 (33%) in the tenotomy group. Pain improved from 3 to 24 months postoperatively (P < .001) with no difference between groups. Cramping was not different between groups, nor was any improvement in cramping seen over time. There were no differences between groups in elbow flexion strength or supination strength. Follow-up magnetic resonance imaging at postoperative 12 months showed that the tenodesis was intact for all patients. CONCLUSION: Tenotomy and tenodesis as treatment for lesions of the long head of biceps tendon both result in good subjective outcomes but there is a higher rate of Popeye deformity in the tenotomy group. REGISTRATION: NCT01747902 ( ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. MacDonald P, Verhulst F, McRae S, et al. Biceps Tenodesis Versus Tenotomy in the Treatment of Lesions of the Long Head of the Biceps Tendon in Patients Undergoing Arthroscopic Shoulder Surgery: A Prospective Double-Blinded Randomized Controlled Trial. Am J Sports Med. 2020. PMID: 32223645. doi:10.1177/0363546520912212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。